跳至主要内容
临床试验/NL-OMON51782
NL-OMON51782已完成不适用

Fully Automated glycemic control with ultrarapid insulin in a bihormonal closed loop System in patients with Type 1 diabetes. - FAST 1

Inreda Diabetic B.V.0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Diagnosed with type 1 diabetes
  • - Treated with the Inreda Artificial Pancreas for a minimum of 1 month
  • - Age between 18 and 75 years
  • - Willing and able to sign informed consent

排除标准

  • - Impaired awareness of hypoglycemia (score >= 4) according to the Gold and/or
  • Clarke questionnaire
  • - Pregnancy and/or breastfeeding
  • - Use of oral antidiabetic agents
  • - Insulinoma
  • - Hypersensitivity reactions to Lyumjev insulin or any of the excipients

研究者

相似试验

Fully Automated glycemic control with ultrarapid... | 临床试验